ADRC News

Words "CLINICAL TRIAL" with hand holding a magic marker. Includes the LUCINDA logo and Wisconsin ADRC logo.

UW study examines potential treatment for Alzheimer’s disease

Researchers are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.
Graphic image charting ten years of progress from the National Institutes of Health

10 years of Alzheimer’s disease and related dementias research

The past decade of National Institutes of Health (NIH)-funded Alzheimer’s disease and related dementias research yielded multiple scientific advances. Learn more via the 2023 NIH dementia research scientific progress report.
Dr. Sterling Johnson at the podium speaking to an audience.

Dr. Sterling Johnson receives outstanding Senior Faculty Research Award

Sterling Johnson, PhD, was recently recognized by the University of Wisconsin Department of Medicine (DOM) as an Outstanding Senior Faculty Researcher.
Drs. Art Walaszek, Cynthia Carlsson, Shenikqua Bouges, and Jack Temple sit around a table talking on stage at the 2023 Fall Community Conversation

2023 Fall Community Conversation features discussion of new Alzheimer’s treatments, resource fair and more

Over 300 guests attended the Fall Community Conversation on September 21, 2023, held at the Middleton Performing Arts Center in Middleton, WI.
Art Walaszek, MD, stands behind a podium to talk to a crowd. The WORT-FM logo and Fall Community Conversation logo appear to the left of the podium

Dr. Art Walaszek speaks about Alzheimer’s treatments and Fall Community Conversation on WORT-FM

Dr. Walaszek chatted with host Jan Miyasaki about what new treatments are available, what the annual event will focus on and how ageism impacts society’s views on aging.
Dr. Sterling Johnson in front of a screen with multiple PET scans and MRI scans. He points on the right side of the screen, where the Wisconsin Public Radio logo has been edited on top of the screen

Dr. Sterling Johnson talks Alzheimer’s disease prevention and WRAP on WPR

Sterling Johnson, PhD, discussed strategies to prevent Alzheimer’s disease and the research being done by the Wisconsin Registry for Alzheimer’s Prevention (WRAP) on Wisconsin Public Radio (WPR).
Red background, white puzzle of a brain with a piece missing in foreground, Wisconsin ADRC logo to the left

Study explores midlife factors associated with blood biomarkers of neurodegeneration and Alzheimer’s disease

Lifestyle and chronic health conditions in middle age, along with a person’s education level, show associations with emerging blood markers of neurodegeneration and Alzheimer's disease.
A group of researchers from the Wisconsin Alzheimer's Disease Research Center (ADRC) surrounding a sign for #AAIC23 at the Alzheimer's Association International Conference in July 2023

UW–Madison Alzheimer’s Disease Experts Travel to Amsterdam for Alzheimer’s Association International Conference

More than 50 students and faculty from the University of Wisconsin–Madison participated and presented at the 2023 Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands.
Nathaniel Chin, MD, at his desk with the Wisconsin Public Radio logo on his computer

Dr. Nathaniel Chin Talks about Lecanemab and Dementia Care with WPR

Nathaniel Chin, MD, joined WPR's Central Time and The Morning Show to discuss the FDA's full approval of Leqembi (lecanemab-Irmb) and dementia care.
Dr. Nathaniel Chin works at his office. On the right, the logos for CNN and JAMA Network are featured on the photo of Chin working.

Dr. Chin discusses Alzheimer’s drug donanemab in JAMA and on CNN

Nathaniel Chin, MD, was quoted in an article by CNN highlighting the Phase 3 clinical trial results of donanemab, a monoclonal antibody seeking approval from the U.S. Food and Drug Administration (FDA).